Point Nemo Capital’s Cardinal Health CAH Stock Holding History

Point Nemo Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,401	Closed	-$1.14M	–	191
2026 Q1	$1.14M	Buy	+5,401	New	+$1.16M	0.75%	60

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Point Nemo Capital's CAH Position: Q2 2026 in Review

Point Nemo Capital sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 5,401 shares — an estimated $1.14M sold.

Point Nemo Capital first reported a position in CAH in Q1 2026 and held it in 1 quarter. The position peaked at $1.14M in Q1 2026. 1,417 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Point Nemo Capital reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
Point Nemo Capital sold 5,401 Cardinal Health shares in Q2 2026, an estimated $1.14M.
Point Nemo Capital first reported a position in Cardinal Health in Q1 2026 and held it in 1 quarter.
Point Nemo Capital's Cardinal Health position peaked at $1.14M in Q1 2026.
1,417 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Point Nemo Capital's 13F filing for Q2 2026, filed 7 Aug 2026.